MYECO GROUP LTD — Capital/Financing Update 2015

Aug 16, 2015

FOR IMMEDIATE RELEASE

==> picture [175 x 80] intentionally omitted <==

TO: COMPANY ANNOUNCEMENTS OFFICE

ASX LIMITED DATE: 17 August 2015

- Stellar Films Australia Investor Update

The Board of SECOS Group Ltd (SES) is delighted to provide an investor update with regard to the progress of Stellar Australia’s Cast Film Plant since the merger of Cardia Bioplastics and Stellar Films Group.

As communicated to shareholders at the Extra-ordinary General Meeting, SECOS Group Ltd recognised that one of the key benefits of the merger was the opportunity to re-open Stellar’s Cast Film Manufacturing Plant located in Melbourne, Australia. This plant has the capacity to produce up to 6,000 tonnes of high quality hygiene cast film per annum. Ideal for applications such as nappy back sheets and sanitary napkins, Stellar’s cast films are in high demand by global hygiene companies.

Since the reopening of Stellar’s plant in April 2015, the business has secured sales worth approx. $400,000 per month representing annualised sales revenue of $4,800,000 per annum.

With the plant now running at approximately 30% capacity the potential growth opportunity is significant. Sales projects are underway to grow the business by capitalising on the increasing demand for Stellar’s high quality films.

With increased global demand, the weakening of the Australian Dollar further strengthens Stellar’s competiveness in targeted export markets.

The annualised $4,800,000 sales include orders from leaders in the global hygiene and pet care industries.

SECOS Group Chairman Richard Tegoni stated, “In order to meet sales orders the business re-opened the Stellar Films Australian Manufacturing Plant and ramped up to a 30% production capacity in only a few months since the merger. This is an excellent result for SECOS Group.”

Richard Tegoni

Chairman SECOS Group Limited

About SECOS Group

SECOS Group Limited (ASX CODE: SES) is a leader in sustainable packaging and was formed through the merger of Cardia Bioplastics and Stellar Films Group in April 2015. It develops, manufactures and markets its proprietary high quality cast films and patented renewable resource-based materials and finished products derived from its proprietary Cardia technology for the global packaging and plastic products industries. The company holds a strong patent portfolio and its growth is fuelled by the global trend towards sustainable packaging. The company Headquarters and Global Application Development Centre is in Melbourne, Australia. Cardia Bioplastics’ Product Development Centre and manufacturing plant for resins and finished products is in Nanjing, China. Stellar Films’ manufacturing plants for high quality cast films are located in Melbourne, Australia and Kuala Lumpur, Malaysia. Its Akronn joint venture production plant for silicone coated products is in Kuala Lumpur, Malaysia. Further sales offices are in Australia, Malaysia, China, USA, Brazil and a network of leading distributors across the Americas, Asia and Europe. Visit www.cardiabioplastics.com and www.stellarfilmsgroup.com